missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human LZTR1 Synthetic Peptide
Description
This peptide corresponds to 14 amino acids near the amino terminus of human LZTR1. PEP-1016 can be used as a blocking peptide with polyclonal antibody PA5-20902.
LZTR1, a member of the BTB-kelch superfamily, was initially described as a putative transcriptional regulator based on weak homology to members of the basic leucine zipper-like family, the encoded protein subsequently has been shown to localize exclusively to the Golgi network where it may help stabilize the Golgi complex. Deletion of this gene may be associated with DiGeorge syndrome, a developmental field defect involving the third and fourth pharyngeal pouches, causing the absence of thymus and parathyroid glands, congenital cardiac abnormalities and facial dysmorphism. LZTR1 is tyrosine phosphorylated and subsequently degraded upon induction of apoptosis.
Specifications
Specifications
| Gene ID (Entrez) | 8216 |
| Species | Human |
| Purification Method | purified |
| Accession Number | Q8N653 |
| Common Name | LZTR1 |
| Concentration | 200 μg/mL |
| Content And Storage | -20°C |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formulation | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?